Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial.
Toma S, Bonelli L, Sartoris A, Mira E, Antonelli A, Beatrice F, Giordano C, Benazzo M, Caroggio A, Cavalot AL, Gandolfo S, Garozzo A, Margarino G, Schenone G, Spadini N, Zibordi F, Balzarini F, Serafini I, Miani P, Cortesina G. Toma S, et al. Among authors: giordano c. Oncol Rep. 2003 Nov-Dec;10(6):1895-901. Oncol Rep. 2003. PMID: 14534715 Clinical Trial.
13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group.
Toma S, Bonelli L, Sartoris A, Mira E, Antonelli A, Beatrice F, Giordano C, Benazzo M, Caroggio A, Cavalot AL, Gandolfo S, Garozzo A, Margarino G, Schenone G, Spadini N, Sirotovà Z, Zibordi F, Balzarini F, Serafini I, Miani P, Cortesina G. Toma S, et al. Among authors: giordano c. Oncol Rep. 2004 Jun;11(6):1297-305. Oncol Rep. 2004. PMID: 15138569 Clinical Trial.
Ifosfamide in the treatment of head and neck cancer.
Airoldi M, Cortesina G, Giordano C, Pedani F, Bumma C. Airoldi M, et al. Among authors: giordano c. Oncology. 2003;65 Suppl 2:37-43. doi: 10.1159/000073356. Oncology. 2003. PMID: 14586145 Review.
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study.
Airoldi M, Cattel L, Cortesina G, Giordano C, Pedani F, Recalenda V, Danova M, Gabriele AM, Tagini V, Porta C, Bumma C. Airoldi M, et al. Among authors: giordano c. Am J Clin Oncol. 2004 Apr;27(2):155-63. doi: 10.1097/01.coc.0000054533.02062.09. Am J Clin Oncol. 2004. PMID: 15057155 Clinical Trial.
Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population.
Airoldi M, Gabriele AM, Garzaro M, Raimondo L, Condello C, Beatrice F, Pecorari G, Giordano C. Airoldi M, et al. Among authors: giordano c. Radiother Oncol. 2009 Jul;92(1):105-10. doi: 10.1016/j.radonc.2009.02.005. Epub 2009 Mar 4. Radiother Oncol. 2009. PMID: 19264368 Clinical Trial.
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C, Grillo R, Dongiovanni D, Birocco N, Rampino M, Redda MG, Garibaldi E, Munoz F, Pecorari G, Cavalot A, Garzinodemo P, Buffoni L, Ciuffreda L, Ricardi U, Cortesina G, Giordano C, Fasolis M, Berrone S, Bertetto O, Schena M. Barone C, et al. Among authors: giordano c. Anticancer Res. 2008 Mar-Apr;28(2B):1285-91. Anticancer Res. 2008. PMID: 18505067 Free article. Clinical Trial.
1,406 results